IDiyas

For the Inventor, By the Inventor

Or-Akiva, Israel

Dexcel Pharma Technologies Ltd.


USPTO Granted Patents = 19



Trademarks = 18

Forward Citations = 228

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Adel Penhasi (6 out of 14 patents)

silverMedal Tomer Gold (4 out of 4 patents)

bronzeMedal Ron Schlinger (4 out of 11 patents)

4.  Dan Oren (4 out of 4 patents)

5.  Sheera Moses-Heller (4 out of 4 patents)

6.  Michael Grishko (3 out of 3 patents)

7.  Tal Hagigit (3 out of 3 patents)

8.  Ezra Hanuka (3 out of 5 patents)

9.  Avi Avramoff (3 out of 14 patents)

10.  Eyal Shoshani (3 out of 3 patents)

11.  Abraham Jacob Domb (3 out of 11 patents)

12.  Corinna Tissen (2 out of 2 patents)

13.  Caterina Kreyenborg (2 out of 2 patents)

14.  Elisabeth Meimberg (2 out of 2 patents)

15.  Karl-Heinz Bannefeld (2 out of 2 patents)


19 patents:

1. 12454693 - Nucleic acids for inhibiting expression of transferrin receptor 2 (2025-10-28),
2. 11986554 - Orally disintegrating compositions (2024-05-21),
3. 11304961 - Compositions comprising dexamethasone (2022-04-19),
4. 11299583 - Alternating and semi-alternating poly(ester-anhydride) copolymers (2022-04-12),
5. 11141488 - Compositions comprising biodegradable copolymers for prolonged local release of an antibiotic (2021-10-12),
6. 11096948 - Methods for treatinginfection (2021-08-24),
7. 11077055 - Orally disintegrating compositions (2021-08-03),
8. 10835488 - Stable orally disintegrating pharmaceutical compositions (2020-11-17),
9. 10774176 - Alternating and semi-alternating poly(ester-anhydride) copolymers (2020-09-15),
10. 10736855 - Compositions comprising proton pump inhibitors (2020-08-11),
11. 10537585 - Compositions comprising dexamethasone (2020-01-21),
12. 10172882 - Pharmaceutical compositions comprising ferric citrate and methods for the production thereof (2019-01-08),
13. 10076494 - Stable orally disintegrating pharmaceutical compositions (2018-09-18),
14. 9889090 - Method for treating a periodontal disease (2018-02-13),
15. 9757338 - Sustained-release donepezil formulation (2017-09-12),
Dexcel Pharma Technologies Ltd. is a leading pharmaceutical company specializing in the development and manufacturing of high-quality generic pharmaceuticals. With a focus on innovative methodologies and advanced technologies, Dexcel Pharma provides reliable and cost-effective solutions for various therapeutic areas. The company is committed to maintaining the highest standards of quality, safety, and efficacy in all their products. For more information about Dexcel Pharma Technologies Ltd., please visit their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

19 Patents

#2 in Or-Akiva

#304 in Israel

#31,648 in the World

...
Or-Akiva, Israel

Dexcel Pharma Technologies Ltd.

Forward Citations = 228

31 inventors:

goldMedal Adel Penhasi (6 out of 14 patents)

silverMedal Tomer Gold (4 out of 4 patents)

bronzeMedal Ron Schlinger (4 out of 11 patents)

4.  Dan Oren (4 out of 4 patents)

5.  Sheera Moses-Heller (4 out of 4 patents)

Please report any incorrect information to support@idiyas.com
Loading…